A multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy and safety of daily oral low dose ulipristal acetate

Ended Awarded Last action

Contract number
HHSN27500002
Awardee
Awarding agency
Obligated
$1,672,864

Award facts

Contract value 100% obligated
$1,672,864.23 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 20 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
New York, NY 10032, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00009 -$407
Other Administrative Action P00008 $0
Other Administrative Action P00007 · This is an internal modification to change the common accounting number 8320384 (CRADA). Contraceptive clinical trials network- female sites - task order 2.… $0
Other Administrative Action P00006 · The purpose of this modification is to decrease the planned parenthood league of massachusetts subcontract amount from $163,425 to $91,613 (not to exceed).… $0
Other Administrative Action P00005 · The purpose of this modification is to add additional funds in the amount of $73,872 and to extend the period of performance to december 31, 2021 in order to… $73,872
Other Administrative Action P00004 · Task order title: a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy and safety of daily… $216,484
Other Administrative Action 3 $0
Other Administrative Action 2 $391,798
Other Administrative Action 1 $0
Original award $991,117

About this award

This is a delivery order contract awarded to The Trustees of Columbia University in the City of New York (Columbia University) by the National Institute of Child Health and Human Development (NICHD), a component of the Department of Health and Human Services. The contract is for a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low-dose ulipristal acetate. This is not a set-aside contract. The contract has a ceiling value of $1,672,864.23 and a period of performance through March 31, 2022. Columbia University, a private non-profit research university, has extensive experience conducting biomedical research and providing services to federal government agencies through both contracts and grants. The university has collaborated with other academic institutions and private companies on past projects for the Centers for Disease Control and Prevention, Department of Defense, and other agencies.

Quick answers

Who was awarded contract HHSN27500002?

HHSN27500002 was awarded to The Trustees Of Columbia University In The City Of New York by National Institute of Child Health and Human Development (National Institutes of Health) on July 16, 2013.

How much is contract HHSN27500002 worth?

The government has obligated $1,672,864 on HHSN27500002.

Is contract HHSN27500002 an order under another contract?

Yes. HHSN27500002 is a delivery order under HHSN275201300010I, an indefinite delivery contract.

Was contract HHSN27500002 competed?

The extent of competition for HHSN27500002 was full and open competition. The government received 20 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award